|
41 |
The Economic Impact of Originator-to-Biosimilar Non-medical Switching in the Real-World Setting: A Systematic Literature Review
Enthalten in Advances in therapy 15.11.2021: 1-33
|
|
|
|
42 |
Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn’s Disease in a Real-Life Setting: Results of a Prospective Multicenter Study in Germany
Enthalten in Inflammatory intestinal diseases Bd. 6, 2021, Nr. 1: 48-60
|
|
|
43 |
Joint imaging platform for federated clinical data analytics
Scherer, Jonas. - Freiburg : Universität, 2020
|
|
|
|
44 |
Was tut ein Geschichtsschreiber?
Enthalten in Philologus Bd. 164, 2020, Nr. 2: 250-2689. 19 S.
|
|
|
|
45 |
Online validation of combined mood induction procedures
Marcusson-Clavertz, David. - Ludwig-Maximilians-Universität München, 2019
|
|
|
|
46 |
How Similar Is Biosimilar? A Comparison of Infliximab Therapeutics in Regard to Charge Variant Profile and Antigen Binding Affinity
Enthalten in Biotechnology journal Bd. 14, 2019, Nr. 4. 9 S.
|
|
|
|
47 |
Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1—Biosimilar and Originator Infliximab in the Hospital Setting
Enthalten in BioDrugs 3.4.2019: 1-13
|
|
|
|
48 |
Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2—Biosimilar and Originator Etanercept in the Outpatient Setting
Enthalten in BioDrugs 3.4.2019: 1-8
|
|
|
|
49 |
Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment
Enthalten in Journal of neurology 9.2.2019: 1-6
|
|
|
|
50 |
Bettymania and the Death of Celebrity Culture
Enthalten in Historical social research / Supplement 2019, Nr. 32: 139-164
|
|
Administration
